Olaparib routine clinical practice in Germany - Quality of life interim results of the non-interventional C-PATROL study

被引：0
|
作者：
El-Balat, A. [1 ]
Marme, F. [2 ]
Sehouli, J. [3 ]
Welslau, M. [4 ]
Grabowski, J. P. [5 ,6 ]
Hartkopf, A. [7 ]
Glowik, R. [8 ]
Hilpert, F. [9 ]
机构：
[1] Univ Klinikum Frankfurt, Klin Frauenheilkunde & Geburtshilfe, Frankfurt, Germany
[2] Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Gynecol, Mannheim, Germany
[3] Charite, Ctr Oncol Surg, Dept Gynecol, Berlin, Germany
[4] Med Off Hematooncol, Aschaffenburg, Aschaffenburg, Germany
[5] Charite, Dept Gynecol, Berlin, Germany
[6] Charite, Ctr Oncol Surg, Berlin, Germany
[7] Univ Hosp Tuebingen, Ctr Womens Hlth, Tubingen, Germany
[8] AstraZeneca Germany, Oncol, Wedel, Germany
[9] Jerusalem Hosp Hamburg, Ctr Oncol, Hamburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1718133
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P304
引用
收藏
页码：E188 / E188
页数：1
相关论文
共 50 条
  • [31] Quality of life and efficacy of NEPA as CINV prophylaxis in highly or moderately emetogenic chemotherapy - interim results of a German prospective non-interventional study
    Karthaus, M.
    Schilling, J.
    Rauh, J.
    Heilmann, V.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 184 - 184
  • [32] IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROME (MDS) IN ROUTINE CLINICAL SETTING: AN INTERIM ANALYSIS OF THE NON-INTERVENTIONAL STUDY EXSEPT
    Nolte, F.
    Rubanov, O.
    Kuehn, R. -B.
    Schumann, C.
    Kreil, S.
    Metzgeroth, G.
    Johr, C.
    Albrecht, S.
    Hofmann, W. -K.
    HAEMATOLOGICA, 2015, 100 : 490 - 490
  • [33] Ingenol mebutate as topical treatment for actinic keratosis based on a prospective, non-interventional, multicentre study of real-life clinical practice in Germany: efficacy and quality of life
    Diepgen, Thomas L.
    Eicke, Christoph
    Bastian, Mike
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (04) : 401 - 408
  • [34] Ingenol mebutate as topical treatment for actinic keratosis based on a prospective, non-interventional, multicentre study of real-life clinical practice in Germany: efficacy and quality of life
    Thomas L. Diepgen
    Christoph Eicke
    Mike Bastian
    European Journal of Dermatology, 2019, 29 : 401 - 408
  • [35] Rituximab in Maintenance (RIM): first results from a non-interventional study (NIS) examining routine treatment practice in Follicular Lymphoma (FL) in Germany
    Duehrsen, U.
    Romanowski, F.
    Karnitzschky, K.
    Dieing, A.
    Reiser, M.
    Prange-Krex, G.
    Jentsch-Ullrich, K.
    Lueck, A.
    Kingreen, D.
    Porowski, P.
    Schwinger, U.
    Luft, S.
    Lerchenmueller, C.
    ONKOLOGIE, 2012, 35 : 46 - 46
  • [36] Evolocumab in clinical Practice in Austria: Interim Data on LDL-C Goal Attainment from the European non-interventional HEYMANS Study
    Ebenbichler, Christoph
    Drexel, Heinz
    Hanusch, Ursula
    Hemetsberger, Margit
    Pigard, Nadine
    Toplak, Hermann
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 203 - 204
  • [37] 5 years effectiveness of fingolimod in daily clinical practice: results of the non-interventional study PANGAEA
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 372 - 373
  • [38] PROMiS (a prospective, non-interventional study in US patients with relapsing-remitting multiple sclerosis treated with alemtuzumab in routine clinical practice): interim results on treatment history and satisfaction with alemtuzumab
    Khatri, B. O.
    Morawski, J.
    Chung, L.
    Poole, E.
    Bury, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 948 - 949
  • [39] The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI
    Laux, G.
    PHARMACOPSYCHIATRY, 2012, 45 (07) : 284 - 291
  • [40] Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study
    Leitner, Deborah R.
    Toplak, Hermann
    Kedenko, Ludmilla
    Steinmaurer, Thomas
    Graeff, Verena
    Metzner, Thomas
    Schwaiger, Elisabeth M.
    Prager, Rudolf
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1419 - 1425
12345